MDSAP for Medical Devices

Updated October 26, 2024

Medical devices help clinicians deliver care, but the rules for those devices differ by country. That makes compliance expensive and repetitive. The Medical Device Single Audit Program (MDSAP) was created to reduce that burden. This article explains how MDSAP works, what it does for compliance, where implementation gets hard, and how it may shape future regulation.

Key Takeaways

• MDSAP unifies medical device unifies audits for multiple regulators.
• Participating countries include the US, Canada, Brazil, Australia, Japan.
• Reduces redundant audits, saving time and resources for manufacturers.
• Promotes consistent quality management system oversight.
• MDSAP enhances patient safety through standardized requirements.
• Manufacturers must adapt internal processes for MDSAP compliance.

Table of Contents

• Key Takeaways
• Understanding the MDSAP Program
• The Role of MDSAP in Medical Device Compliance
• Benefits of MDSAP for Medical Devices
• Challenges in Implementing MDSAP
• Future of MDSAP in the Medical Device Industry
• Medical Device Testing FAQs

Why this matters

The FDA's Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (Feb 3, 2026 final guidance) made cybersecurity documentation a gating criterion for clearance under Section 524B of the FD&C Act. Reviewers now apply this guidance to mdsap simplifies international compliance the same way they apply software lifecycle expectations from IEC 62304 and security risk-management expectations from AAMI TIR57 and ANSI/AAMI SW96:2023.

Gaps in this area are the single most common driver of first-cycle cybersecurity Additional Information (AI) requests. The FDA's FY2024 CDRH performance reports show cybersecurity is among the top deficiency categories cited in 510(k) and PMA AI letters, behind only software documentation and clinical evidence. Treating it as a checklist exercise rather than a design-controlled engineering artifact is what creates the gap.

Understanding the MDSAP Program

MDSAP was set up to simplify international compliance for medical device manufacturers. It aligns audit procedures across participating countries, including the United States, Canada, Brazil, Australia, and Japan. MDSAP uses one standardized process to assess a manufacturer’s quality management system.

The Purpose of MDSAP

The main goal of MDSAP is to let medical device manufacturers complete a single audit that satisfies multiple regulators. That cuts duplicated work, lowers cost, and frees resources for product development.

Key Participants in MDSAP

MDSAP depends on coordination between regulatory authorities and medical device manufacturers. Participating regulators set the standard audit process and requirements. Manufacturers must meet MDSAP requirements and undergo audits by authorized auditing organizations.

A standardized audit process also gives manufacturers a clearer view of what multiple regulators expect. That makes compliance more predictable and promotes consistency across the industry.

MDSAP also supports collaboration among participating countries. By aligning audit procedures, regulators can share practices and improve their own frameworks. That exchange helps improve the safety and effectiveness of medical devices.

The Role of MDSAP in Medical Device Compliance

MDSAP helps manufacturers meet global regulatory requirements with less duplication. Its value shows up in global compliance, the audit process, and the operational benefits for manufacturers.

MDSAP’s Impact on Global Regulatory Compliance

The old model required separate audits by each regulator. That meant repeated assessments, higher costs, and more internal effort. MDSAP removes much of that duplication by allowing one audit to satisfy multiple regulatory authorities. That reduces audit fatigue and can speed time to market.

MDSAP also pushes participating countries toward more consistent safety and quality expectations. When requirements are better aligned, manufacturers can target multiple markets with less rework, and healthcare providers get devices assessed against more consistent standards.

The Process of MDSAP Auditing

The MDSAP audit process has five stages: planning, conducting, reporting, closing, and monitoring. In planning, the authorized auditing organization works with the manufacturer to define the audit scope and build the audit plan. That includes identifying applicable requirements and the documents and evidence to review.

In the conduct stage, auditors perform on-site assessments of the manufacturer’s quality management system and verify compliance. They interview staff, review records, and inspect operations to confirm that processes match regulatory requirements. This is where gaps and nonconformities are identified.

After the audit, the auditing organization issues a report with findings, observations, nonconformities, and improvement opportunities. The manufacturer then addresses the nonconformities. That may require corrective actions, procedure updates, or additional evidence.

Once corrective actions are implemented, the audit closes and ongoing compliance is monitored. Monitoring can include surveillance audits or follow-up assessments to confirm the corrective actions work.

Benefits of MDSAP for Medical Devices

MDSAP gives medical device manufacturers several practical advantages.

Streamlining International Compliance

Before MDSAP, manufacturers had to work through each country’s regulatory requirements on their own. That took significant time and resources and created a barrier to entering global markets. MDSAP provides one framework that supports compliance across multiple jurisdictions. That saves time, reduces duplicated effort, and helps manufacturers bring devices to market faster.

Reducing Audit Time and Resources

A single MDSAP audit replaces multiple separate audits. That cuts redundant assessments and reduces the administrative overhead tied to scheduling, preparation, and follow-up. Manufacturers can put that time back into product quality, R&D, and other business-critical work. It also improves efficiency and competitiveness.

Enhancing Patient Safety

See also: When to Hire a Device Security Consultant vs. Build In-House, Cybersecurity Is Now a QMS Requirement, and Why Medical Device Cybersecurity Is Nothing Like Enterprise.

A core MDSAP objective is better patient safety through stronger quality oversight. The audit process requires manufacturers to show compliance with internationally recognized quality management system requirements. That includes design controls, risk management, and post-market surveillance processes. Meeting those requirements helps reduce device failures, adverse events, and other safety issues.

Challenges in Implementing MDSAP

MDSAP has clear benefits, but implementation is not frictionless.

Overcoming Initial Implementation Hurdles

Manufacturers often need to adjust existing quality management systems to meet MDSAP requirements. That can take time and effort. It may require updating documentation, training staff, and adding controls to close compliance gaps.

Internal communication is another common problem. Organizations need clear communication so each team understands what changed and what they own. That gets harder in larger companies with multiple departments and sites.

Addressing Common Concerns with MDSAP

Some manufacturers worry about stricter audit scrutiny and whether auditing organizations are competent. Those concerns are common, but participating regulatory authorities maintain oversight of authorized auditing organizations to verify consistency and competence.

Regulators assess the auditing organizations’ experience, expertise, and compliance with international standards. They also audit those organizations on an ongoing basis. That oversight helps preserve the integrity of the assessment process.

Manufacturers can also reduce friction by engaging early with the auditing organization. Direct communication helps clarify expectations, answer process questions, and improve audit readiness.

Future of MDSAP in the Medical Device Industry

MDSAP has already changed how many manufacturers approach international compliance.

Predicted Trends for MDSAP

As the medical device industry changes, MDSAP will likely become more prominent. More countries may join, extending the program’s reach and expanding the use of a common compliance framework.

Technology may also change how audits are performed. Artificial intelligence and data analytics could make audits faster and more targeted. For example, automated analysis could help identify risks and improvement areas earlier, which would improve audit efficiency.

MDSAP’s Potential Impact on Future Regulations

MDSAP’s success in aligning requirements across multiple countries may influence how other industries approach global compliance. It offers a working model for regulators and industry groups trying to reduce duplication across borders.

The program also shows the value of direct collaboration between regulators and manufacturers. That kind of coordination will matter more as technologies change and regulations need to keep pace. MDSAP creates a structure for that ongoing dialogue.

Conclusion

MDSAP simplifies international compliance for medical device manufacturers by aligning audit procedures and requirements across participating countries. It reduces duplicate audits, lowers resource demands, and gives manufacturers a more efficient path to global compliance. It also supports better consistency in quality oversight and patient safety.

Implementation still takes work. Manufacturers may need to update quality systems, train teams, and address audit concerns. But with planning and support, those challenges are manageable.

MDSAP will likely keep growing in reach and influence. As more regulators align around shared expectations and audit models, the medical device industry gets a more efficient compliance path and patients benefit from stronger oversight.

How Blue Goat approaches this

Blue Goat Cyber's medical device practice is led by engineers with CISSP, OSCP, and prior military red-team backgrounds. We treat cybersecurity documentation as design-controlled engineering output, not a submission template, every artifact (threat model, SBOM, security risk assessment, penetration test, labeling) traces back to a controlled requirement and a verified result.

Our engagements deliver the full Feb 3, 2026 guidance documentation set scoped to the device's risk profile, integrated with the existing IEC 62304 software lifecycle and ISO 14971 risk file. See our medical device cybersecurity services for the full scope. If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost.

FAQ

What is MDSAP?

MDSAP, or the Medical Device Single Audit Program, allows a single audit of a medical device manufacturer's quality management system to satisfy the regulatory requirements of multiple participating countries. This program helps reduce the burden of separate audits for each country, streamlining compliance.

Which countries participate in MDSAP?

Key participants in MDSAP include the United States (the FDA), Canada, Brazil, Australia, and Japan. These regulatory authorities collaborate to align audit procedures and requirements under the program.

How does MDSAP benefit medical device manufacturers?

MDSAP benefits manufacturers by significantly reducing the need for multiple, country-specific audits, which saves time, resources, and administrative overhead. It also facilitates quicker market access in participating countries and promotes greater consistency in quality management system expectations.

What are the challenges of implementing MDSAP?

Initial implementation challenges for MDSAP include adjusting existing quality management systems to meet updated requirements, training staff, and Ensure clear internal communication. Manufacturers may also need to address concerns about audit scrutiny and auditor competence.

How does MDSAP improve patient safety?

MDSAP enhances patient safety by requiring manufacturers to demonstrate compliance with internationally recognized quality management system requirements, including design controls, risk management, and post-market surveillance. This rigorous oversight helps reduce device failures and adverse events.

What is the FDA's role in MDSAP?

The FDA is a key participant in MDSAP, collaborating with other regulatory authorities to define and implement the program's standards. The FDA accepts MDSAP audit reports as a substitute for routine inspections, helping to streamline compliance for manufacturers seeking to market devices in the United States.

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.